Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo

2005 ◽  
Vol 11 (5) ◽  
pp. 556-561 ◽  
Author(s):  
Igor Klyubin ◽  
Dominic M Walsh ◽  
Cynthia A Lemere ◽  
William K Cullen ◽  
Ganesh M Shankar ◽  
...  
2008 ◽  
Vol 14 (8) ◽  
pp. 837-842 ◽  
Author(s):  
Ganesh M Shankar ◽  
Shaomin Li ◽  
Tapan H Mehta ◽  
Amaya Garcia-Munoz ◽  
Nina E Shepardson ◽  
...  

Nature ◽  
2002 ◽  
Vol 416 (6880) ◽  
pp. 535-539 ◽  
Author(s):  
Dominic M. Walsh ◽  
Igor Klyubin ◽  
Julia V. Fadeeva ◽  
William K. Cullen ◽  
Roger Anwyl ◽  
...  

2017 ◽  
Vol 326 ◽  
pp. 237-243 ◽  
Author(s):  
Sheng-Xiao Zhang ◽  
Hong-Yan Cai ◽  
Xiao-Wen Ma ◽  
Li Yuan ◽  
Jun Zhang ◽  
...  

2020 ◽  
pp. 1-12 ◽  
Author(s):  
Yingxia Liang ◽  
Frank Raven ◽  
Joseph F. Ward ◽  
Sherri Zhen ◽  
Siyi Zhang ◽  
...  

2008 ◽  
Vol 64 (6) ◽  
pp. 618-627 ◽  
Author(s):  
Zhongcong Xie ◽  
Deborah J. Culley ◽  
Yuanlin Dong ◽  
Guohua Zhang ◽  
Bin Zhang ◽  
...  

2006 ◽  
Vol 572 (2) ◽  
pp. 477-492 ◽  
Author(s):  
Matthew Townsend ◽  
Ganesh M. Shankar ◽  
Tapan Mehta ◽  
Dominic M. Walsh ◽  
Dennis J. Selkoe

Neuroscience ◽  
2014 ◽  
Vol 277 ◽  
pp. 6-13 ◽  
Author(s):  
H.-Y. Cai ◽  
C. Hölscher ◽  
X.-H. Yue ◽  
S.-X. Zhang ◽  
X.-H. Wang ◽  
...  

2015 ◽  
Vol 112 (32) ◽  
pp. E4465-E4474 ◽  
Author(s):  
Takayuki Ohnishi ◽  
Masako Yanazawa ◽  
Tomoya Sasahara ◽  
Yasuki Kitamura ◽  
Hidekazu Hiroaki ◽  
...  

Neurodegeneration correlates with Alzheimer’s disease (AD) symptoms, but the molecular identities of pathogenic amyloid β-protein (Aβ) oligomers and their targets, leading to neurodegeneration, remain unclear. Amylospheroids (ASPD) are AD patient-derived 10- to 15-nm spherical Aβ oligomers that cause selective degeneration of mature neurons. Here, we show that the ASPD target is neuron-specific Na+/K+-ATPase α3 subunit (NAKα3). ASPD-binding to NAKα3 impaired NAKα3-specific activity, activated N-type voltage-gated calcium channels, and caused mitochondrial calcium dyshomeostasis, tau abnormalities, and neurodegeneration. NMR and molecular modeling studies suggested that spherical ASPD contain N-terminal-Aβ–derived “thorns” responsible for target binding, which are distinct from low molecular-weight oligomers and dodecamers. The fourth extracellular loop (Ex4) region of NAKα3 encompassing Asn879 and Trp880 is essential for ASPD–NAKα3 interaction, because tetrapeptides mimicking this Ex4 region bound to the ASPD surface and blocked ASPD neurotoxicity. Our findings open up new possibilities for knowledge-based design of peptidomimetics that inhibit neurodegeneration in AD by blocking aberrant ASPD–NAKα3 interaction.


Sign in / Sign up

Export Citation Format

Share Document